Kite Pharma seeks a Director, Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune. This role leads global market access strategies for autoimmune programs from early development to launch, coordinating with HEOR, Medical Affairs and Commercial teams.
Based in California with a hybrid schedule, you will shape payer perspectives, evidence plans and pricing to support patient access and successful launches across major markets.
#J-18808-Ljbffr
We are seeking a motivated Global Value & Access Director, Autoimmune Cell Therapy to join 1110 Kite Pharma, Inc. in El Segundo, CA, United States.
The advertised compensation is 226.000 - 293.000.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Global Value & Access Director, Autoimmune Cell Therapy role in the description above.